Composés du manganèse : Questions médicales fréquentes
Nom anglais: Manganese Compounds
Descriptor UI:D017895
Tree Number:D01.530
Termes MeSH sélectionnés :
Case-Control Studies
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Composés du manganèse : Questions médicales les plus fréquentes",
"headline": "Composés du manganèse : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Composés du manganèse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-09",
"dateModified": "2025-03-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Composés du manganèse"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Produits chimiques inorganiques",
"url": "https://questionsmedicales.fr/mesh/D007287",
"about": {
"@type": "MedicalCondition",
"name": "Produits chimiques inorganiques",
"code": {
"@type": "MedicalCode",
"code": "D007287",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D01"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Composés du manganèse",
"alternateName": "Manganese Compounds",
"code": {
"@type": "MedicalCode",
"code": "D017895",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "George Psomas",
"url": "https://questionsmedicales.fr/author/George%20Psomas",
"affiliation": {
"@type": "Organization",
"name": "Department of General and Inorganic Chemistry, Faculty of Chemistry, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece. Electronic address: gepsomas@chem.auth.gr."
}
},
{
"@type": "Person",
"name": "Wenbo Liu",
"url": "https://questionsmedicales.fr/author/Wenbo%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Sub-department of Environmental Technology, Wageningen University & Research, 6708WG, Wageningen, The Netherlands. Electronic address: wesssnbo.liu@wur.nl."
}
},
{
"@type": "Person",
"name": "Donald R Smith",
"url": "https://questionsmedicales.fr/author/Donald%20R%20Smith",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Environmental Toxicology, University of California at Santa Cruz, Santa Cruz, California, United States."
}
},
{
"@type": "Person",
"name": "Somshuvra Mukhopadhyay",
"url": "https://questionsmedicales.fr/author/Somshuvra%20Mukhopadhyay",
"affiliation": {
"@type": "Organization",
"name": "Division of Pharmacology and Toxicology, College of Pharmacy, and Institute for Neuroscience, The University of Texas at Austin, Austin, Texas, United States."
}
},
{
"@type": "Person",
"name": "Courtney J Mercadante",
"url": "https://questionsmedicales.fr/author/Courtney%20J%20Mercadante",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A case-control study on immunologic markers of patients with vitiligo.",
"datePublished": "2022-10-14",
"url": "https://questionsmedicales.fr/article/36244264",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.biopha.2022.113785"
}
},
{
"@type": "ScholarlyArticle",
"name": "Case-Control Study of Long COVID, Sapporo, Japan.",
"datePublished": "2023-04-12",
"url": "https://questionsmedicales.fr/article/37044126",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3201/eid2905.221349"
}
},
{
"@type": "ScholarlyArticle",
"name": "Endothelium-biomarkers for postthrombotic syndrome: a case-control study.",
"datePublished": "2023-03-29",
"url": "https://questionsmedicales.fr/article/37016998",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MBC.0000000000001192"
}
},
{
"@type": "ScholarlyArticle",
"name": "Risk Factors for Postoperative Pneumonia: A Case-Control Study.",
"datePublished": "2022-07-08",
"url": "https://questionsmedicales.fr/article/35875004",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2022.913897"
}
},
{
"@type": "ScholarlyArticle",
"name": "Significance of temperature in antimuscarinic toxicity: a case-control study.",
"datePublished": "2022-06-23",
"url": "https://questionsmedicales.fr/article/35735006",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/15563650.2022.2088378"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Produits chimiques inorganiques",
"item": "https://questionsmedicales.fr/mesh/D007287"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés du manganèse",
"item": "https://questionsmedicales.fr/mesh/D017895"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Composés du manganèse - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Composés du manganèse",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Composés du manganèse",
"description": "Comment diagnostiquer une intoxication au manganèse ?\nQuels examens sont recommandés pour évaluer l'exposition au manganèse ?\nQuels symptômes indiquent une exposition au manganèse ?\nQuelle est la méthode de dépistage du manganèse dans le sang ?\nQuels antécédents médicaux sont pertinents pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D017895?mesh_terms=Case-Control+Studies&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Composés du manganèse",
"description": "Quels sont les symptômes d'une intoxication aiguë au manganèse ?\nComment se manifestent les troubles neurologiques liés au manganèse ?\nY a-t-il des symptômes psychologiques associés au manganèse ?\nQuels signes cliniques sont observés chez les travailleurs exposés ?\nLes symptômes d'intoxication au manganèse sont-ils réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D017895?mesh_terms=Case-Control+Studies&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Composés du manganèse",
"description": "Comment prévenir l'exposition au manganèse dans l'industrie ?\nQuelles sont les recommandations pour les travailleurs exposés au manganèse ?\nY a-t-il des limites d'exposition au manganèse ?\nComment réduire l'exposition au manganèse dans l'environnement ?\nLes tests de dépistage sont-ils recommandés pour les populations à risque ?",
"url": "https://questionsmedicales.fr/mesh/D017895?mesh_terms=Case-Control+Studies&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Composés du manganèse",
"description": "Quel est le traitement principal pour l'intoxication au manganèse ?\nComment gérer les symptômes neurologiques causés par le manganèse ?\nY a-t-il des médicaments spécifiques pour traiter l'intoxication ?\nQuelle est l'importance de l'arrêt de l'exposition au manganèse ?\nLes traitements sont-ils efficaces à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D017895?mesh_terms=Case-Control+Studies&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Composés du manganèse",
"description": "Quelles complications peuvent survenir après une exposition prolongée ?\nL'intoxication au manganèse peut-elle affecter la santé mentale ?\nQuels sont les risques de maladies respiratoires liés au manganèse ?\nY a-t-il des effets à long terme sur la fonction cognitive ?\nLes complications sont-elles réversibles après traitement ?",
"url": "https://questionsmedicales.fr/mesh/D017895?mesh_terms=Case-Control+Studies&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Composés du manganèse",
"description": "Qui est le plus à risque d'intoxication au manganèse ?\nLes enfants sont-ils plus vulnérables au manganèse ?\nQuels facteurs environnementaux augmentent le risque d'exposition ?\nY a-t-il des prédispositions génétiques à l'intoxication ?\nComment l'alimentation influence-t-elle le risque d'exposition ?",
"url": "https://questionsmedicales.fr/mesh/D017895?mesh_terms=Case-Control+Studies&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication au manganèse ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par des tests sanguins et urinaires pour mesurer les niveaux de manganèse."
}
},
{
"@type": "Question",
"name": "Quels examens sont recommandés pour évaluer l'exposition au manganèse ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens neurologiques et des imageries cérébrales peuvent être effectués pour évaluer les effets."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition au manganèse ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des troubles neurologiques, des problèmes respiratoires et des douleurs abdominales peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quelle est la méthode de dépistage du manganèse dans le sang ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La spectrométrie de masse est souvent utilisée pour mesurer les niveaux de manganèse dans le sang."
}
},
{
"@type": "Question",
"name": "Quels antécédents médicaux sont pertinents pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'exposition professionnelle ou environnementale au manganèse sont cruciaux."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une intoxication aiguë au manganèse ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vomissements, des douleurs abdominales et des vertiges."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les troubles neurologiques liés au manganèse ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent se manifester par des tremblements, des troubles de la coordination et des changements de comportement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes psychologiques associés au manganèse ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme l'anxiété, la dépression et des troubles cognitifs peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont observés chez les travailleurs exposés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des troubles moteurs et des changements de personnalité sont souvent observés."
}
},
{
"@type": "Question",
"name": "Les symptômes d'intoxication au manganèse sont-ils réversibles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains symptômes peuvent être réversibles, mais d'autres peuvent devenir permanents sans traitement."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition au manganèse dans l'industrie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures de sécurité, comme des équipements de protection individuelle, doivent être mises en place."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour les travailleurs exposés au manganèse ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs doivent suivre des protocoles de sécurité et subir des examens médicaux réguliers."
}
},
{
"@type": "Question",
"name": "Y a-t-il des limites d'exposition au manganèse ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des limites d'exposition professionnelle sont établies par des organismes de santé publique."
}
},
{
"@type": "Question",
"name": "Comment réduire l'exposition au manganèse dans l'environnement ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réglementations sur les émissions industrielles et des contrôles environnementaux sont nécessaires."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils recommandés pour les populations à risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests réguliers sont conseillés pour les populations à risque d'exposition au manganèse."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour l'intoxication au manganèse ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal consiste à éliminer l'exposition et à administrer des agents chélateurs si nécessaire."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes neurologiques causés par le manganèse ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réhabilitation neurologique et la thérapie physique peuvent aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments spécifiques pour traiter l'intoxication ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme la D-penicillamine peuvent être utilisés pour chélater le manganèse."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'arrêt de l'exposition au manganèse ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'arrêt de l'exposition est crucial pour prévenir des dommages supplémentaires et favoriser la récupération."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces à long terme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité dépend de la gravité de l'intoxication et de la rapidité du traitement administré."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une exposition prolongée ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques graves, comme la maladie de Parkinson, peuvent se développer."
}
},
{
"@type": "Question",
"name": "L'intoxication au manganèse peut-elle affecter la santé mentale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles mentaux comme la dépression et l'anxiété peuvent être exacerbés par l'exposition."
}
},
{
"@type": "Question",
"name": "Quels sont les risques de maladies respiratoires liés au manganèse ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition peut entraîner des maladies respiratoires chroniques, comme la bronchite."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme sur la fonction cognitive ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des études montrent que l'exposition au manganèse peut entraîner des déficits cognitifs durables."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles après traitement ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes selon la gravité."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'intoxication au manganèse ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs dans les industries minières et de fabrication sont les plus à risque."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables au manganèse ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants sont plus vulnérables en raison de leur développement neurologique rapide."
}
},
{
"@type": "Question",
"name": "Quels facteurs environnementaux augmentent le risque d'exposition ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pollution industrielle et l'utilisation de pesticides contenant du manganèse augmentent le risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des prédispositions génétiques à l'intoxication ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines prédispositions génétiques peuvent influencer la susceptibilité à l'intoxication au manganèse."
}
},
{
"@type": "Question",
"name": "Comment l'alimentation influence-t-elle le risque d'exposition ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en manganèse peut augmenter le risque d'intoxication, surtout en cas d'exposition professionnelle."
}
}
]
}
]
}
Vitiligo is a depigmentation skin disease often coexisting with other autoimmune disorders. The prevalence is 0.5-2 % of the world's population. A combination of genetic, environmental and biochemical...
We conducted a cross-sectional survey among SARS-CoV-2-positive persons and negative controls in Sapporo, Japan, to clarify symptoms of long COVID. We collected responses from 8,018 participants, 3,69...
The postthrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT). Increase knowledge on the PTS pathophysiology and novel biomarkers are needed in order to predict PTS dev...
A case-control study was conducted. Inclusion criteria were symptomatic and confirmed DVT patients treated with anticoagulants for at least 3 months. Villalta score was performed at the time of inclus...
Thirty two patients and 61 controls were included. PTS patients showed higher levels of CEC (0.56/μl (0.34-1.5) vs. 0.20/μl (0.11-0.77); P = 0.04) and EPC (0.75/μl (0.38-1.52) vs. 0.09/μl (0.05-0.82);...
The formation and early resolution of DVT are characterized by inflammation and endothelial/platelet activation. We have identified possible novel biomarkers such as CEC, EPC and fractalkine for the d...
Postoperative pneumonia is a preventable complication associated with adverse outcomes, that greatly aggravates the medical expenses of patients. The goal of our study is to identify risk factors and ...
A matched 1:1 case-control study, including adult patients who underwent surgery between January 2020 and June 2020, was conducted in the Second Affiliated Hospital of Kunming Medical University in Ch...
Out of 17,190 surgical patients, 264 (1.54%) experienced postoperative pneumonia. Increased age, chronic obstructive pulmonary disease, emergency surgery, postoperative reduced albumin, prolonged vent...
Postoperative pneumonia is associated with severe clinical outcomes. We identified six independent risk factors that can aid in risk stratification and management of patients at risk of postoperative ...
www.chictr.org.cn, identifier: chiCTR2100045986....
Antimuscarinic toxicity can result in temperature dysregulation, but the clinical significance of this is unclear. The objective of this study was to compare peak temperatures between antimuscarinic p...
This was a case-control analysis at two large, urban, academic medical centers from January 1, 2016, through December 31, 2021. We compared peak temperature (...
Fifty-six patients met inclusion criteria of which 23 developed severe outcomes: 16 seizures, 9 cases with hypotension, 5 intubations, and 2 ventricular dysrhythmias. Tmax amongst all patients ranged ...
Maximum temperatures did not differ between patients with and without severe outcomes in the setting of antimuscarinic toxicity, and temperature was poorly predictive of outcomes. Our findings suggest...
Asbestos lung content is regarded as the most reliable tool for causal attribution of malignant mesothelioma (MM) to previous asbestos exposures. However, there is a lack of studies on asbestos burden...
Asbestos lung content has been assessed on formalin-fixed lung fragments using scanning electron microscopy coupled with energy dispersion spectroscopy (SEM-EDS) on individuals deceased from MM (cases...
Asbestos and asbestos bodies (ABs) were found, respectively, in 73.7% and 43.2% of cases and in 28 and 22% of controls; in MM cases the most represented asbestos types were crocidolite and amosite, wh...
The results suggest a correlation between asbestos burden in lungs and MM risk. The different concentration of chrysotile, as well as the different width of asbestos fibers in MM males and females mig...
Psoriasis (PsO) is a chronic inflammatory skin condition, often accompanied by psoriatic arthritis (PsA) and linked to various comorbidities and increased mortality rates. This study aimed to explore ...
Idiopathic intracranial hypertension (IIH) is a condition that mostly affects obese women of childbearing age but has been reported to be temporally related to new diagnoses of anemia. Despite these r...
Consecutive IIH patients were recruited from neuro-ophthalmology clinics and matched by age and sex to consecutive patients attending neuro-ophthalmology clinics with diagnoses other than IIH. Complet...
One hundred twenty-three IIH patients and 113 controls were included in the study. More IIH patients than controls had anemia (22.8%, 28/123 vs 10.6%, 12/113, P = 0.01) with an odds ratio of 2.48 (95%...
Idiopathic intracranial hypertension patients have a higher prevalence of anemia compared with non-IIH neuro-ophthalmology patients. The anemia was mostly mild and may be explained by other factors re...
Adverse drug reactions (ADRs) caused by opioid drugs show individual differences. Our objective was to explore the association between gene polymorphism and ADRs induced by opioid drugs....
Evidence-based medical data analysis was conducted for genes related to ADRs induced by opioid drugs to select target genes. Sixty patients with cancer pain who had ADRs after taking opioid drugs (mor...
Based on a database search and evidence-based medical data, we identified CYP2D6*10, CYP3A5*3, ABCB1, and OPRM1 as target genes for detection. The results of statistical analysis showed no significant...
Polymorphism of ABCB1 (062rs1045642) is related to ADRs caused by oxycodone, and the incidence of ADRs is higher with the allele T. Polymorphism of ABCB1 is expected to become a clinical predictor of ...
The effect of systemic hormone therapy (HT) on dementia risk is unclear. Our aim was to investigate the association between HT and dementia....
This register-based study consists of a nested case-control study and a co-twin control design, which controls for familial confounding, including shared genetics....
Through Danish national registries from 1995 to 2011, we identified: a) 2700 female singletons with incident dementia and 13,492 matched controls; b) 288 female twins with incident dementia and co-twi...
The odds ratio (OR) for the association between systemic HT and dementia was 1.05, 95% CI = [0.93-1.19] in singletons and 2.10, 95% CI = [0.99-4.46] in twins. A statistically significant association w...
Using Danish nationwide registries and controlling for education and for familial factors in a subsample, systemic HT was found to be associated with increased dementia risk if used before 2003, when ...